AIMA
LH icon

Ables Iannone Moore & Associates’s Labcorp LH Stock Holding History

Ables Iannone Moore & Associates’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$273K Hold
975
– – 0.15% 56
2026
Q1 		$260K Sell
975
-240
-20% -$65K 0.15% 55
2025
Q4 		$305K Sell
1,215
-10
-0.8% -$2.66K 0.17% 54
2025
Q3 		$352K Sell
1,225
-250
-17% -$67K 0.2% 51
2025
Q2 		$387K Sell
1,475
-75
-5% -$18.3K 0.24% 49
2025
Q1 		$361K Hold
1,550
– – 0.25% 46
2024
Q4 		$356K Sell
1,550
-75
-5% -$17.2K 0.22% 47
2024
Q3 		$364K Hold
1,625
– – 0.23% 47
2024
Q2 		$331K Hold
1,625
– – 0.22% 47
2024
Q1 		$355K Hold
1,625
– – 0.25% 46
2023
Q4 		$369K Buy
+1,625
New +$341K 0.28% 46

Other funds holding LH

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
HPCM
Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return
MCM
McRae Capital Management Morristown, New Jersey $508M AUM 14.21% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
WIC
WealthBridge Investment Counsel Calgary, Alberta, Canada $375M AUM 37.9% 1-Year Est. Return
GIA
GHP Investment Advisors Denver, Colorado $2.72B AUM 27.58% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Ables Iannone Moore & Associates's LH Position: Q2 2026 in Review

Ables Iannone Moore & Associates held its Labcorp (LH) position steady in Q2 2026 at 975 shares worth $273K. The position accounts for 0.15% of the portfolio, ranked #56.

Ables Iannone Moore & Associates first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $387K in Q2 2025. 178 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Ables Iannone Moore & Associates held 975 shares of Labcorp worth $273K as of Q2 2026.
  • Ables Iannone Moore & Associates left its Labcorp share count unchanged in Q2 2026.
  • Labcorp made up 0.15% of Ables Iannone Moore & Associates's portfolio in Q2 2026, its #56 holding.
  • Ables Iannone Moore & Associates first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • Ables Iannone Moore & Associates's Labcorp position peaked at $387K in Q2 2025.
  • 178 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Ables Iannone Moore & Associates's 13F filing for Q2 2026, filed 13 Jul 2026.